Search

Your search keyword '"Floridia M"' showing total 342 results

Search Constraints

Start Over You searched for: Author "Floridia M" Remove constraint Author: "Floridia M"
342 results on '"Floridia M"'

Search Results

1. Usefulness of calcaneal quantitative ultrasound stiffness for the evaluation of bone health in HIV-1-infected subjects: comparison with dual X-ray absorptiometry

2. Raltegravir, tenofovir, and emtricitabine in an HIV-Infected patient with HCV chronic hepatitis, NNRTI intolerance and protease inhibitors-induced severe liver Toxicity

3. Long-COVID in Italy: a country perspective

4. Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

7. Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

8. Italian good practice recommendations on management of persons with Long-COVID

10. CD4/CD8 ratio in pregnant women with HIV and its association with pregnancy outcome: data from a national study in Italy

13. Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study

14. Weight Gain during Pregnancy in Women with HIV Receiving Different Antiretroviral Regimens

15. Comorbidity status of deceased COVID-19 in-patients in Italy

18. Vaginal delivery in women with HIV in Italy: results of 5 years of implementation of the national SIGO-HIV protocol

19. COVID-19 mortality among migrants living in Italy

20. Prevalence and clinical correlates of dementia among COVID-19-related deaths in Italy

21. Sex differences in clinical phenotype and transitions of care among individuals dying of COVID-19 in Italy

23. Amniocentesis and chorionic villus sampling in HIV-infected pregnant women: a multicentre case series

24. Evolving treatment implementation among HIV- infected pregnant women and their partners: Results from a national surveillance study in Italy, 2001-2015

26. Evolving treatment implementation among HIV- infected pregnant women and their partners: Results from a national surveillance study in Italy, 2001-2015

27. Mapping the medical outcomes study HIV health survey (MOS-HIV) to the EuroQoL 5 Dimension (EQ-5D-3 L) utility index

31. CD4/CD8 ratio in pregnant women with HIV and its association with pregnancy outcome: data from a national study in Italy.

34. Abacavir/Lamivudine and Tenofovir/Emtricitabine in Pregnant Women with Hiv: Laboratory and Clinical Outcomes in an Observational National Study

35. Weight Gain during Pregnancy in Women with HIV Receiving Different Antiretroviral Regimens

36. A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease

37. Atazanavir and darunavir in pregnant women with HIV: evaluation of laboratory and clinical outcomes from an observational national study

38. Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection

40. Pregnant with HIV before age 25: Data from a large national study in Italy, 2001-2016

41. Tuberculosis case finding with combined rapid point of care assays (Xpert® MTB/RIF and LAM) in HIV-positive individuals starting antiretroviral treatment in Mozambique

43. Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV

44. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF

45. Body Mass Index and Weight Gain in Pregnant Women With HIV: A National Study in Italy

46. Treatment change in pregnancy is a significant risk factor for detectable HIV-1 RNA in plasma at end of pregnancy

47. Atazanavir and lopinavir profile in pregnant women with HIV: tolerability, activity and pregnancy outcomes in an observational national study

48. Pregnancy outcomes and cytomegalovirus DNAaemia in HIV-infected pregnant women with CMV

50. Cytomegalovirus (CMV) DNA load in breast milk of human immunodeficiency virus-positive women and infant CMV infection acquisition are not reduced with long-term antiretroviral therapy

Catalog

Books, media, physical & digital resources